Your browser doesn't support javascript.
loading
Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
Cibula, David; Akilli, Huseyin; Jarkovsky, Jiri; van Lonkhuijzen, Luc; Scambia, Giovanni; Meydanli, Mehmet Mutlu; Ortiz, David Isla; Falconer, Henrik; Abu-Rustum, Nadeem R; Odetto, Diego; Klát, Jaroslav; Dos Reis, Ricardo; Zapardiel, Ignacio; Di Martino, Giampaolo; Presl, Jiri; Laky, Rene; López, Aldo; Weinberger, Vit; Obermair, Andreas; Pareja, Rene; Poncová, Renata; Mom, Constantijne; Bizzarri, Nicolò; Borcinová, Martina; Aslan, Koray; Salcedo Hernandez, Rosa Angélica; Fons, Guus; Benesová, Klára; Dostálek, Lukás; Ayhan, Ali.
Affiliation
  • Cibula D; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic. Electronic address: dc@davidcibula.cz.
  • Akilli H; Baskent University School of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology, Ankara, Turkey.
  • Jarkovsky J; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • van Lonkhuijzen L; Amsterdam University Medical Centers, Center for Gynaecologic Oncology Amsterdam, Amsterdam, the Netherlands.
  • Scambia G; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
  • Meydanli MM; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Ortiz DI; Gynecology Oncology Center, National Institute of Cancerology Mexico, Mexico.
  • Falconer H; Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Abu-Rustum NR; Memorial Sloan Kettering Cancer Center, USA.
  • Odetto D; Department of Gynecologic Oncology, Hospital Italiano de Buenos Aires, CABA, Buenos Aires, Argentina.
  • Klát J; Department of Obstetrics and Gynecology, Faculty of Medicine, University Hospital and University of Ostrava, Ostrava, Czech Republic.
  • Dos Reis R; Department of Gynecological Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
  • Zapardiel I; Gynecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.
  • Di Martino G; Gynaecologic Surgical Unit, ASST-Monza, San Gerardo Hospital,University of Milano-Bicocca, Monza, Italy.
  • Presl J; Department of Gynaecology and Obstetrics, University Hospital Pilsen, Charles University, Pilsen, Czech Republic.
  • Laky R; Gynecology, Medical University of Graz, Graz, Austria.
  • López A; Department of Gynecological Surgery, National Institute of Neoplastic Diseases, Lima, Peru.
  • Weinberger V; University Hospital Brno, Medical Faculty of Masaryk University, Brno, Czech Republic.
  • Obermair A; Queensland Centre for Gynaecological Cancer; The University of Queensland, Australia.
  • Pareja R; Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
  • Poncová R; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic.
  • Mom C; Amsterdam University Medical Centers, Center for Gynaecologic Oncology Amsterdam, Amsterdam, the Netherlands.
  • Bizzarri N; Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
  • Borcinová M; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic.
  • Aslan K; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health and Research Hospital, University of Health Sciences, Ankara, Turkey.
  • Salcedo Hernandez RA; Gynecology Oncology Center, National Institute of Cancerology Mexico, Mexico.
  • Fons G; Amsterdam University Medical Centers, Center for Gynaecologic Oncology Amsterdam, Amsterdam, the Netherlands.
  • Benesová K; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Dostálek L; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), Prague, Czech Republic.
  • Ayhan A; Baskent University School of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology, Ankara, Turkey.
Gynecol Oncol ; 170: 195-202, 2023 03.
Article in En | MEDLINE | ID: mdl-36706646
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Uterine Cervical Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Uterine Cervical Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article